Michael J. Purvis

Michael joined us as Executive Vice President, General Counsel & Corporate Strategy in March 2021. With 25 years of legal experience, Michael was most recently Vice President, Assistant General Counsel & Assistant Secretary at Incyte Corp. from February 2015 until February 2021, where he helped lead and build the legal group as Incyte transformed into an S&P 500 global biopharmaceutical company focused on oncology, inflammation and autoimmunity, and dermatology. Prior to Incyte, Michael was Senior Associate General Counsel & Assistant Secretary at Auxilium Pharmaceuticals, where he oversaw disclosure, securities law matters, strategic transactions and corporate matters until Auxilium’s successful acquisition by Endo Pharmaceuticals. Previously, Michael held a similar role at West Pharmaceutical Services from 2009 to 2010. Prior to West, Michael served as Senior Counsel at a securities trading firm, Susquehanna International Group, from 2003 to 2009, where he supported the healthcare research group and helped establish investment banking and private equity departments. Michael began his legal career in 1997 at Sullivan & Cromwell in New York City, before joining Dechert LLP in Philadelphia in 2000. Michael received his J.D., manga cum laude, from Boston University School of Law and his B.A., manga cum laude, in Latin and Classical Humanities, from The Catholic University of America in Washington, D.C.